Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease.

Michael G NannaAdam J NelsonKevin HaynesSonali ShambhuZubin EapenMark J CzirakySara B CalvertNeha J PagidipatiChristopher B Granger

Published in: Journal of the American Geriatrics Society (2022)

Less than half of eligible older adults with ASCVD are on statins and only a minority of patients are receiving more intensive lipid-lowering to improve outcomes.

Keyphrases

cardiovascular disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
fatty acid
type diabetes
prognostic factors
coronary artery disease
adipose tissue
cardiovascular risk factors
combination therapy
community dwelling